Total Payments
$14,206
2024 Payments
$1,146
Companies
35
Transactions
1,083
Medicare Patients
3,690
Medicare Billing
$351,766
Payment Breakdown by Category
Food & Beverage$13,944 (98.2%)
Education$262.26 (1.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,944 | 1,034 | 98.2% |
| Education | $262.26 | 49 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amarin Pharma Inc. | $1,754 | 91 | $0 (2023) |
| Amgen Inc. | $1,500 | 94 | $0 (2024) |
| Lilly USA, LLC | $1,425 | 129 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,307 | 72 | $0 (2024) |
| Novo Nordisk Inc | $1,163 | 129 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,146 | 86 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,104 | 132 | $0 (2024) |
| PFIZER INC. | $642.91 | 43 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $598.16 | 40 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $487.69 | 39 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,146 | 70 | AstraZeneca Pharmaceuticals LP ($187.84) |
| 2023 | $1,464 | 86 | Amgen Inc. ($283.90) |
| 2022 | $1,476 | 82 | Amarin Pharma Inc. ($223.04) |
| 2021 | $864.36 | 45 | Amgen Inc. ($237.26) |
| 2020 | $637.56 | 41 | Amgen Inc. ($164.66) |
| 2019 | $2,318 | 218 | Lilly USA, LLC ($316.91) |
| 2018 | $2,582 | 231 | Amarin Pharma Inc. ($378.00) |
| 2017 | $3,719 | 310 | Amarin Pharma Inc. ($631.34) |
All Payment Transactions
1,083 individual payment records from CMS Open Payments — Page 1 of 44
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: VACCINES | ||||||
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Respiratory | ||||||
| 12/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $30.91 | General |
| Category: DIABETES | ||||||
| 12/09/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $1.92 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $26.99 | General |
| Category: Bone Health | ||||||
| 12/02/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: RESPIRATORY | ||||||
| 11/27/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: Cardio-renal | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $2.79 | General |
| Category: RESPIRATORY | ||||||
| 11/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: Obesity | ||||||
| 11/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $27.10 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: Bone Health | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: Respiratory | ||||||
| 10/24/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: Bone Health | ||||||
| 10/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: DIABETES | ||||||
| 10/22/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Cardio-renal | ||||||
| 10/08/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: Diabetes | ||||||
| 10/03/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: Respiratory | ||||||
| 10/01/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: Bone Health | ||||||
| 09/25/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: VACCINE | ||||||
| 09/19/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: Diabetes | ||||||
| 09/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $3.97 | General |
| Category: Diabetes | ||||||
| 09/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $2.57 | General |
| Category: Diabetes | ||||||
| 09/12/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: Endocrinology | ||||||
| 09/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.23 | General |
| Category: DIABETES | ||||||
| 09/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,008 | 1,520 | $268,553 | $104,034 |
| 2022 | 11 | 718 | 1,117 | $183,485 | $55,700 |
| 2021 | 11 | 951 | 1,324 | $209,184 | $94,114 |
| 2020 | 11 | 1,013 | 1,369 | $204,032 | $97,918 |
Total Patients
3,690
Total Services
5,330
Medicare Billing
$351,766
Procedure Codes
44
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 179 | 179 | $60,334 | $47,912 | 79.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 307 | 728 | $146,998 | $32,656 | 22.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 137 | 205 | $28,005 | $8,817 | 31.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 179 | 179 | $9,354 | $5,461 | 58.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 48 | 57 | $6,489 | $3,304 | 50.9% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 73 | 86 | $7,829 | $3,224 | 41.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 23 | 23 | $3,637 | $925.76 | 25.5% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 17 | 17 | $3,471 | $681.75 | 19.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 17 | 17 | $871.34 | $545.70 | 62.6% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 16 | 16 | $506.08 | $348.78 | 68.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 12 | 13 | $1,059 | $158.21 | 14.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 291 | 607 | $122,565 | $29,131 | 23.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 140 | 188 | $25,632 | $8,461 | 33.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 142 | 173 | $19,694 | $8,067 | 41.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 17 | 17 | $5,109 | $4,457 | 87.2% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 11 | 11 | $1,427 | $1,405 | 98.5% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 19 | 21 | $3,518 | $1,355 | 38.5% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 25 | 26 | $2,367 | $968.37 | 40.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 27 | 27 | $906.66 | $838.38 | 92.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 16 | 16 | $537.28 | $513.61 | 95.6% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 16 | 16 | $506.08 | $336.88 | 66.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 14 | 15 | $1,221 | $166.32 | 13.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 278 | 555 | $111,538 | $33,566 | 30.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 214 | 214 | $31,959 | $29,581 | 92.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 189 | 251 | $28,574 | $14,617 | 51.2% |
About Dr. Mark Nishihara, M.D
Dr. Mark Nishihara, M.D is a Internal Medicine healthcare provider based in Aiea, Hawaii. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/25/2007. The National Provider Identifier (NPI) number assigned to this provider is 1134330491.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Nishihara, M.D has received a total of $14,206 in payments from pharmaceutical and medical device companies, with $1,146 received in 2024. These payments were reported across 1,083 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($13,944).
As a Medicare-enrolled provider, Nishihara has provided services to 3,690 Medicare beneficiaries, totaling 5,330 services with total Medicare billing of $351,766. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Aiea, HI
- Active Since 05/25/2007
- Last Updated 02/11/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1134330491
Products in Payments
- Vascepa (Drug) $1,754
- JARDIANCE (Drug) $716.94
- EVENITY (Biological) $715.92
- TRULICITY (Drug) $497.38
- TRADJENTA (Drug) $494.42
- FARXIGA (Drug) $470.39
- Livalo (Drug) $389.06
- SYMBICORT (Drug) $386.97
- Kerendia (Drug) $378.73
- Aimovig (Biological) $324.28
- QVAR (Drug) $317.62
- Ozempic (Drug) $311.69
- TRELEGY ELLIPTA (Drug) $284.73
- Victoza (Drug) $270.26
- JANUVIA (Drug) $254.69
- Rybelsus (Drug) $251.59
- TOUJEO (Drug) $250.58
- Prolia (Biological) $234.57
- Edarbi (Drug) $212.75
- SHINGRIX (Biological) $207.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Aiea
Roy Ebisu, Md, MD
Internal Medicine — Payments: $18,765
Internal Medicine $18,765
Stephen Miyasato, Md, MD
Internal Medicine — Payments: $18,084
Internal Medicine $18,084
Dr. Francis Buto, M.d, M.D
Internal Medicine — Payments: $14,868
Internal Medicine $14,868
Dr. Alan Oki, Md, MD
Internal Medicine — Payments: $14,573
Internal Medicine $14,573
Dr. Malissa Iida-Takashima, Md, MD
Internal Medicine — Payments: $13,761
Internal Medicine $13,761
Dr. Michael Mihara, M.d, M.D
Internal Medicine — Payments: $13,527
Internal Medicine $13,527